Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02776098 · ClinicalTrials.gov registry record
Muscle Accrual and Function in Cystic Fibrosis-Impact of Glucose Intolerance
A clinical trial of Cystic Fibrosis, sponsored by Children's Hospital of Philadelphia.
- Completed
- Registry status
- 54
- Enrollment target
- 2
- Study locations
NCT02776098 is a study of Cystic Fibrosis that has completed, run by Children's Hospital of Philadelphia. The registered enrollment target is 54 participants, below the 179-participant average among 169 other Cystic Fibrosis trials with a reported enrollment target (70% lower). The trial reports 2 study locations across 1 state.
The verdict
NCT02776098, a study of Cystic Fibrosis, has completed, sponsored by Children's Hospital of Philadelphia.
- COMPLETED
- Registry status
- 54 participants
- Enrollment target
- 2
- Study locations
Study Summary
This study will investigate the link between glucose abnormalities and elements critical to muscle function including mass, composition and energy metabolism. the primary goal of the study is to determine whether Cystic Fibrosis (CF) disease is associated with muscle dysfunction, especially in the presence of glucose intolerance. This is a longitudinal cohort study of 3 main groups: CF subjects without Cystic Fibrosis-related diabetes (CFRD), healthy matched controls and CF subjects with newly diagnosed CFRD started on insulin therapy.
Conditions Studied
Study Locations (2)
Pennsylvania
- Children's Hospital of Philadelphia - Philadelphia
- University of Pennsylvania - Philadelphia
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 54 participants |
| Start Date | 2016-05 |
| Est. Completion | 2024-03-04 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02776098
The ClinicalTrials.gov registry entry for NCT02776098 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 54 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 179-participant average among 169 other Cystic Fibrosis trials with a reported enrollment target (70% lower). The listed sponsor is Children's Hospital of Philadelphia, which has 431 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Cystic Fibrosis appearing as the primary indexed condition, and to 0 interventions.
NCT02776098 reports 2 study locations spanning 1 distinct geographic area - top geographies include Pennsylvania.
Frequently Asked Questions
What is clinical trial NCT02776098 about?
NCT02776098 is a clinical study titled "Muscle Accrual and Function in Cystic Fibrosis-Impact of Glucose Intolerance". This study will investigate the link between glucose abnormalities and elements critical to muscle function including mass, composition and energy metabolism. the primary goal of the study is to determine whether Cystic Fibrosis (CF) disease is associated with muscle dysfunction, especially in the p...
What is the current status of trial NCT02776098?
This trial is currently completed. The enrollment target is 54 participants. The study started on 2016-05. Estimated completion is 2024-03-04.
What conditions does trial NCT02776098 study?
This clinical trial studies the following conditions: Cystic Fibrosis.
Who is sponsoring clinical trial NCT02776098?
This trial is sponsored by Children's Hospital of Philadelphia, which has 431 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02776098 being conducted?
This trial has 2 study locations across Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Cystic Fibrosis
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Exercise in Child Health
RECRUITING · NA
-
Targeting Inflammation With Losartan to Improve Response to Modulator Therapy in Cystic Fibrosis.
RECRUITING · Phase 2
-
A Pilot and Feasibility Study to Evaluate High vs Low Glycemic Index Mixed Meal Tolerance Test in Adolescents and Young Adults With Cystic Fibrosis
RECRUITING · NA
-
A Research Study to Advance the CF Therapeutics Pipeline for People Without Modulators
RECRUITING
-
Assessing Tenapanor as a Treatment of CF-related Constipation.
RECRUITING · Phase 3
-
Genetics of Insulin and Incretins in Cystic Fibrosis
RECRUITING
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.